Page 13 - Access Pool News Today

WHO and Unitaid welcome the signing of a voluntary licensing agreement by the Medicines Patent Pool (MPP) and MSD to facilitate affordable access to

Developing countries have been hit with an endless tide of inadequate gestures and broken promises from rich countries and pharmaceutical companies

Developing countries have been hit with an endless tide of inadequate gestures and broken promises from rich countries and pharmaceutical companies, who are failing to deliver billions of doses they promised while blocking the real solutions to vaccine inequality, according to a new report published today by the People’s Vaccine Alliance.

WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s Covid-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues

COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable access of COVID-19 health products by boosting their supply.

UNITED NATIONS/GENEVA, Oct 20: WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine

Australia has only delivered 6% of the 60 million vaccines pledged through the COVAX initiative. Developing countries have been hit with an endless

UNITED NATIONS/GENEVA, Oct 20: WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine

Covid-19: One year since call for vaccine tech to be shared